Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...

A 22-year-old is urging others to “advocate for your body” after a ruptured ovarian cyst nearly claimed her life. Daisy Wilson’s ordeal began in October 2024 after she began experiencing a ...

Traditional treatment paradigms often fail to provide the necessary specificity required to exclusively target ovarian cancer cells without affecting surrounding healthy tissue. Alfa Cytology's ...

Stage 3 ovarian cancer has spread outside the pelvis into the abdominal ... means the cancer in the lymph nodes is larger than 1cm Stage 3A2 means that there are cancer cells in the peritoneum. It ...

As discussed previously, cytology may be a useful tool for this purpose. Although we cannot diagnose all patients with ovarian, tubal or peritoneal cancer correctly by cytological diagnosis alone ...

Continued approval of ImmunoGen’s first-in-class ADC directed against FRα – a cell-surface protein highly expressed in ovarian cancer – might be contingent upon verification and description ...